Navigation Links
DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC

("LPMTM") oral drug delivery technology for the oral delivery of leuprolide for the treatment of prostate cancer and endometriosis.

Through its Biodefense Division, DOR is developing biomedical countermeasures pursuant to the recently enacted Project BioShield Act of 2004. DOR's biodefense products in development are recombinant subunit vaccines designed to protect against the lethal effects of exposure to ricin toxin and botulinum toxin. DOR's ricin toxin vaccine, RiVax™, has been shown to be safely tolerated and immunogenic in a Phase 1 clinical trial in normal volunteers.

For further information regarding DOR BioPharma, please visit the Company's website located at http://www.dorbiopharma.com">www.dorbiopharma.com.

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, that reflect DOR BioPharma, Inc.'s current expectations about its future results, performance, prospects and opportunities, including statements regarding the potential use of orBec® for the treatment of gastrointestinal GVHD and the prospects for regulatory filings for orBec®. Where possible, DOR has tried to identify these forward-looking statements by using words such as "anticipates," "believes," "intends," or similar expressions. These statements are subject to a number of risks, uncertainties and other factors that could cause actual events or results in future periods to differ materially from what is expressed in, or implied by, these statements. DOR cannot assure you that it will be able to successfully develop or commercialize products based on its technology, including orBec®, particularly in light of the significant uncertainty inherent in developing vaccines against bioterror threats, manufacturing and conducting preclinical and clinical trials of vaccines, and obtaining regulatory approvals
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
2. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
3. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
4. Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory Drugs
5. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
6. AVI BioPharma Reports Positive Pre-Clinical Influenza Data
7. Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
8. CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
9. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:5/17/2013)...  Sorrento Therapeutics, Inc. (OTCBB: SRNE; or STI) ... Business Technology Transfer Research (STTR) grant (#1R42AI098182-02) from ... (NIAID), a division of the National Institutes of ... antibody therapeutics to combat Staphylococcus aureus ... methicillin-resistant S. aureus (MRSA), was renewed ...
(Date:5/17/2013)... CHAMPAIGN, Ill. , May 17, 2013  Sony ... new Sony SP6800 Spectral Analyzer (SP6800).  Sony will be ... 2013, which will be held at the ... San Diego, California , from May 20 - ... Sony,s second analytical system, incorporating commercial audio-visual technologies into ...
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- The ... recombinant proteins, is placing renewed emphasis on alternate ... rise as a number of factors are converging ... pharmaceutical makers and their delivery device partners . ... refractory conditions, the growing trend toward self-administration for ...
Breaking Medicine Technology:Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3
(Date:5/17/2013)... (PRWEB) May 17, 2013 Fighting addiction ... complications, but for diabetics, treatment is more difficult and ... medical care to monitor blood sugar levels and administer ... properly, a drug rehab for diabetics needs ... and nutritional needs of the diabetic, and has experience ...
(Date:5/17/2013)... "screen time" and sleep on mood, memory and ... at the 2013 Intel International Science and Engineering ... school students. The awards are coordinated by the ... the National Institutes of Health, and Friends of ... Intel ISEF Addiction Science Awards were presented at ...
(Date:5/17/2013)... Too few obstetrics-gynecology residents in the United States receive ... issues for the rapidly growing number of older American ... ob/gyn residents and found that fewer than one in ... though seven in 10 would like to receive it. ... -- those soon to complete their training -- said ...
(Date:5/17/2013)... (SACRAMENTO, Calif.) Working with lab mice models of ... novel molecular target for the design of drugs that ... medications against MS. , The findings of the ... EMBO Molecular Medicine could have therapeutic applications for ... disorders associated with loss of white matter, which is ...
(Date:5/17/2013)... GA (PRWEB) May 17, 2013 The ... news on the site for women using the vaginal ... panel shows the number of claims alleging blood clots ... was created to improve the safety of patients using ... research and legal news. Visitors can find out if ...
Breaking Medicine News(10 mins):Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 2Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 3Health News:Study of 'screen time' on mood, memory, and cognition wins top NIH Addiction Science Award 2Health News:Study of 'screen time' on mood, memory, and cognition wins top NIH Addiction Science Award 3Health News:Study of 'screen time' on mood, memory, and cognition wins top NIH Addiction Science Award 4Health News:Is Menopause Overlooked in U.S. Medical Schools? 2Health News:Study identifies new approach to improving treatment for MS and other conditions 2Health News:Latest Court Records Show 6% Increase In NuvaRing Lawsuits, DrugRisks Notes 2
... Four days after an Indian pilgrim died of respiratory ... the Indo-China border, another Indian woman too succumbed// to ... that one of the holiest pilgrim sites in Asia ... Indian travellers. ,Meenakshi Devi Shriram Bhoyar, a ...
... the Intellectual Property law raised a lot of oppositions from ... mainly aim to restrict the government from buying the cheap ... tuberculosis. Officials point out to the fact that these changes ... are cheaper. The NGOs are also against an amendment as ...
... agreed to provide a grant assistance of Rs.190 million ... (IIPI) campaign// in India this year, parliament was informed ... Welfare Minister Anbumani Ramadoss told the Lok Sabha: 'The ... UNICEF to be used during the pulse polio rounds ...
... a therapy that eases iron overload, according to researchers. ... the current issue of Human Reproduction. ,Women ... which attaches to ligaments and organs in the abdomen. ... infertility and adhesions. About 10 percent of women may ...
... Uttar Pradesh government has asked medical officials in the district ... villages of Loni and Bhojpur blocks// where two suspected cases ... directives were issued by the UP Health Secretary and the ... about it, District Magistrate M K S Sundaram said today., ...
... Women in the age of 40 to 50 years are ... play a vital role in the disease because of the ... A new study has examined the role played by estradiol, ... women and how it works in the development of osteoarthritis. ...
Cached Medicine News:Health News:High-altitude Illness Affects Pilgrims of Mansarovar 2Health News:Knee Osteoarthritis May Be Triggered By Low Levels Of Estrogen 2
High sensitive, specific one step immunochromatographic assay for human infectious disease...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
Detection of Malarial antigen in Human whole blood....
The KAT-Quick Malaria test was designed for the diagnosis of Malaria, in laboratories, the home and for medical kits when travelling into malaria regions....
Medicine Products: